Literature DB >> 9466372

Is avascular necrosis of the femoral head the result of inhibition of angiogenesis?

D W Smith1.   

Abstract

An hypothesis is offered here that the pathogenesis of avascular necrosis (AVN) of the femoral head is based on the inhibition of angiogenesis. Well-established facts supporting this hypothesis are: 1, the lesion of AVN is vascular obliteration often leading to infarction; 2, glucocorticoids, which are a risk factor for AVN, are inhibitors of angiogenesis; 3, interferons, which are now being used in the treatment of multiple sclerosis, hepatitis, leukemias, and hemangiomas are inhibitors of angiogenesis, and other endogenously produced cytokines are also inhibitors; 4, constituents of cartilage are inhibitors of angiogenesis, explaining the subchondral location of AVN; 5, angiography of the femoral head indicates the need for continual renewal of its blood supply, shows the inhibition of revascularization by steroids, and suggests that the stress of weight bearing makes the femoral head particularly vulnerable. This hypothesis has implications for the therapeutic use of inhibitors of angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9466372     DOI: 10.1016/s0306-9877(97)90067-0

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  17 in total

1.  Bilateral osteonecrosis of the tarsus coincident with glioblastoma multiforme.

Authors:  M Heliotis; E Tsiridis; S T Donell; T J Marshall; D G Scott
Journal:  J R Soc Med       Date:  2001-12       Impact factor: 5.344

Review 2.  Osteonecrosis in children after therapy for malignancy.

Authors:  Sue C Kaste; Evguenia J Karimova; Michael D Neel
Journal:  AJR Am J Roentgenol       Date:  2011-05       Impact factor: 3.959

3.  Nilotinib induced avascular necrosis of femoral head in an adult chronic myeloid leukemia patient.

Authors:  Shinto Francis Thekkudan; Soniya Nityanand
Journal:  J Clin Orthop Trauma       Date:  2017-11-24

4.  The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus.

Authors:  T C M Castro; H Lederman; M T A Terreri; W I Caldana; S C Kaste; M O Hilário
Journal:  Br J Radiol       Date:  2010-11-16       Impact factor: 3.039

5.  Risk factors and pathogenesis of steroid-induced osteonecrosis of femoral head - A scoping review.

Authors:  Vikas Birla; Abhishek Vaish; Raju Vaishya
Journal:  J Clin Orthop Trauma       Date:  2021-10-13

6.  Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study.

Authors:  John H Wessel; Thomas B Dodson; Athanasios I Zavras
Journal:  J Oral Maxillofac Surg       Date:  2008-04       Impact factor: 1.895

Review 7.  Chemotherapy-associated osteonecrosis in cancer patients with solid tumours: a systematic review.

Authors:  Katharine Shim; Mary J MacKenzie; Eric Winquist
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

8.  5-Azacytidine and trichostatin A enhance the osteogenic differentiation of bone marrow mesenchymal stem cells isolated from steroid-induced avascular necrosis of the femoral head in rabbit.

Authors:  Peng Zhang; Fulin Tao; Qinghu Li; Shuai Wu; Baisheng Fu; Ping Liu
Journal:  J Biosci       Date:  2019-09       Impact factor: 1.826

9.  Minimally invasive treatment for osteonecrosis of the femoral head with angioconductive bioceramic rod.

Authors:  Yajie Lu; Xiao Lu; Minghui Li; Xiantao Chen; Youwen Liu; Xianfa Feng; Jinwei Yu; Chengquan Zhang; Dongsheng Niu; Siqun Wang; Zhen Wang; Jianxi Lu
Journal:  Int Orthop       Date:  2018-04-10       Impact factor: 3.075

10.  Skeletal scintigraphy manifestations of hematologic disorders.

Authors:  Shrikant V Solav; Ritu Bhandari; Pallavi Solav
Journal:  Indian J Nucl Med       Date:  2012-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.